United States Chimeric Antibody Market Report 2016

United States Chimeric Antibody Market Report 2016

1 Chimeric Antibody Overview

1.1 Product Overview and Scope of Chimeric Antibody

1.2 Classification of Chimeric Antibody

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Chimeric Antibody

1.3.1 Medical care

1.3.2 Experiment

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Chimeric Antibody (2011-2021)

1.4.1 USA Chimeric Antibody Sales and Growth Rate (2011-2021)

1.4.2 USA Chimeric Antibody Revenue and Growth Rate (2011-2021)

2 USA Chimeric Antibody Competition by Manufacturers

2.1 USA Chimeric Antibody Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Chimeric Antibody Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Chimeric Antibody Average Price by Manufactures (2015 and 2016)

2.4 Chimeric Antibody Market Competitive Situation and Trends

2.4.1 Chimeric Antibody Market Concentration Rate

2.4.2 Chimeric Antibody Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Chimeric Antibody Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Chimeric Antibody Sales and Market Share by Type (2011-2016)

3.2 USA Chimeric Antibody Revenue and Market Share by Type (2011-2016)

3.3 USA Chimeric Antibody Price by Type (2011-2016)

3.4 USA Chimeric Antibody Sales Growth Rate by Type (2011-2016)

4 USA Chimeric Antibody Sales (Volume) by Application (2011-2016)

4.1 USA Chimeric Antibody Sales and Market Share by Application (2011-2016)

4.2 USA Chimeric Antibody Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Chimeric Antibody Manufacturers Profiles/Analysis

5.1 A.G. Scientific, Inc. (US)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Chimeric Antibody Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 A.G. Scientific, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Abbott Diagnostics (US)

5.2.2 Chimeric Antibody Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Abbott Diagnostics (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Agilent Technologies, Inc. (US)

5.3.2 Chimeric Antibody Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Agilent Technologies, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 BD Biosciences (US)

5.4.2 Chimeric Antibody Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 BD Biosciences (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Beckman Coulter, Inc. (US)

5.5.2 Chimeric Antibody Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Beckman Coulter, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 bioMerieux (France)

5.6.2 Chimeric Antibody Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 bioMerieux (France) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Bio-Rad Laboratories, Inc. (US)

5.7.2 Chimeric Antibody Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Bio-Rad Laboratories, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 F. Hoffmann-La Roche Ltd. (Switzerland)

5.8.2 Chimeric Antibody Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 F. Hoffmann-La Roche Ltd. (Switzerland) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Gallus Immunotech, Inc. (Canada)

5.9.2 Chimeric Antibody Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Gallus Immunotech, Inc. (Canada) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 GE Healthcare (UK)

5.10.2 Chimeric Antibody Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 GE Healthcare (UK) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Lonza Biologics Ltd. (Switzerland)

5.12 Merck KGaA (Germany)

5.13 Meridian Life Science, Inc. (US)

5.14 PerkinElmer, Inc. (US)

5.15 Promega Corporation (US)

5.16 Qiagen N.V. (Netherlands)

5.17 R&D Systems (US)

5.18 SDIX, LLC (US)

5.19 Shimadzu Corporation (Japan)

5.20 Takara Bio, Inc. (Japan)

5.21 Thermo Fisher Scientific Inc. (US)

5.22 Wako Pure Chemical Industries Ltd. (Japan)

5.23 Waters Corp. (US)

6 Chimeric Antibody Manufacturing Cost Analysis

6.1 Chimeric Antibody Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Chimeric Antibody

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Chimeric Antibody Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Chimeric Antibody Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Chimeric Antibody Market Forecast (2016-2021)

10.1 USA Chimeric Antibody Sales, Revenue Forecast (2016-2021)

10.2 USA Chimeric Antibody Sales Forecast by Type (2016-2021)

10.3 USA Chimeric Antibody Sales Forecast by Application (2016-2021)

10.4 Chimeric Antibody Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Chimeric Antibody

Table Classification of Chimeric Antibody

Figure USA Sales Market Share of Chimeric Antibody by Type in 2015

Table Application of Chimeric Antibody

Figure USA Sales Market Share of Chimeric Antibody by Application in 2015

Figure Medical care Examples

Figure Experiment Examples

Figure USA Chimeric Antibody Sales and Growth Rate (2011-2021)

Figure USA Chimeric Antibody Revenue and Growth Rate (2011-2021)

Table USA Chimeric Antibody Sales of Key Manufacturers (2015 and 2016)

Table USA Chimeric Antibody Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Chimeric Antibody Sales Share by Manufacturers

Figure 2016 Chimeric Antibody Sales Share by Manufacturers

Table USA Chimeric Antibody Revenue by Manufacturers (2015 and 2016)

Table USA Chimeric Antibody Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Chimeric Antibody Revenue Share by Manufacturers

Table 2016 USA Chimeric Antibody Revenue Share by Manufacturers

Table USA Market Chimeric Antibody Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Chimeric Antibody Average Price of Key Manufacturers in 2015

Figure Chimeric Antibody Market Share of Top 3 Manufacturers

Figure Chimeric Antibody Market Share of Top 5 Manufacturers

Table USA Chimeric Antibody Sales by Type (2011-2016)

Table USA Chimeric Antibody Sales Share by Type (2011-2016)

Figure USA Chimeric Antibody Sales Market Share by Type in 2015

Table USA Chimeric Antibody Revenue and Market Share by Type (2011-2016)

Table USA Chimeric Antibody Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Chimeric Antibody by Type (2011-2016)

Table USA Chimeric Antibody Price by Type (2011-2016)

Figure USA Chimeric Antibody Sales Growth Rate by Type (2011-2016)

Table USA Chimeric Antibody Sales by Application (2011-2016)

Table USA Chimeric Antibody Sales Market Share by Application (2011-2016)

Figure USA Chimeric Antibody Sales Market Share by Application in 2015

Table USA Chimeric Antibody Sales Growth Rate by Application (2011-2016)

Figure USA Chimeric Antibody Sales Growth Rate by Application (2011-2016)

Table A.G. Scientific, Inc. (US) Basic Information List

Table A.G. Scientific, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Figure A.G. Scientific, Inc. (US) Chimeric Antibody Sales Market Share (2011-2016)

Table Abbott Diagnostics (US) Basic Information List

Table Abbott Diagnostics (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott Diagnostics (US) Chimeric Antibody Sales Market Share (2011-2016)

Table Agilent Technologies, Inc. (US) Basic Information List

Table Agilent Technologies, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Agilent Technologies, Inc. (US) Chimeric Antibody Sales Market Share (2011-2016)

Table BD Biosciences (US) Basic Information List

Table BD Biosciences (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table BD Biosciences (US) Chimeric Antibody Sales Market Share (2011-2016)

Table Beckman Coulter, Inc. (US) Basic Information List

Table Beckman Coulter, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Beckman Coulter, Inc. (US) Chimeric Antibody Sales Market Share (2011-2016)

Table bioMerieux (France) Basic Information List

Table bioMerieux (France) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table bioMerieux (France) Chimeric Antibody Sales Market Share (2011-2016)

Table Bio-Rad Laboratories, Inc. (US) Basic Information List

Table Bio-Rad Laboratories, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bio-Rad Laboratories, Inc. (US) Chimeric Antibody Sales Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List

Table F. Hoffmann-La Roche Ltd. (Switzerland) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Chimeric Antibody Sales Market Share (2011-2016)

Table Gallus Immunotech, Inc. (Canada) Basic Information List

Table Gallus Immunotech, Inc. (Canada) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Gallus Immunotech, Inc. (Canada) Chimeric Antibody Sales Market Share (2011-2016)

Table GE Healthcare (UK) Basic Information List

Table GE Healthcare (UK) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table GE Healthcare (UK) Chimeric Antibody Sales Market Share (2011-2016)

Table Lonza Biologics Ltd. (Switzerland) Basic Information List

Table Lonza Biologics Ltd. (Switzerland) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lonza Biologics Ltd. (Switzerland) Chimeric Antibody Sales Market Share (2011-2016)

Table Merck KGaA (Germany) Basic Information List

Table Merck KGaA (Germany) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck KGaA (Germany) Chimeric Antibody Sales Market Share (2011-2016)

Table Meridian Life Science, Inc. (US) Basic Information List

Table Meridian Life Science, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Meridian Life Science, Inc. (US) Chimeric Antibody Sales Market Share (2011-2016)

Table PerkinElmer, Inc. (US) Basic Information List

Table PerkinElmer, Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table PerkinElmer, Inc. (US) Chimeric Antibody Sales Market Share (2011-2016)

Table Promega Corporation (US) Basic Information List

Table Promega Corporation (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Promega Corporation (US) Chimeric Antibody Sales Market Share (2011-2016)

Table Qiagen N.V. (Netherlands) Basic Information List

Table Qiagen N.V. (Netherlands) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Qiagen N.V. (Netherlands) Chimeric Antibody Sales Market Share (2011-2016)

Table R&D Systems (US) Basic Information List

Table R&D Systems (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table R&D Systems (US) Chimeric Antibody Sales Market Share (2011-2016)

Table SDIX, LLC (US) Basic Information List

Table SDIX, LLC (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table SDIX, LLC (US) Chimeric Antibody Sales Market Share (2011-2016)

Table Shimadzu Corporation (Japan) Basic Information List

Table Shimadzu Corporation (Japan) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Shimadzu Corporation (Japan) Chimeric Antibody Sales Market Share (2011-2016)

Table Takara Bio, Inc. (Japan) Basic Information List

Table Takara Bio, Inc. (Japan) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takara Bio, Inc. (Japan) Chimeric Antibody Sales Market Share (2011-2016)

Table Thermo Fisher Scientific Inc. (US) Basic Information List

Table Thermo Fisher Scientific Inc. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Thermo Fisher Scientific Inc. (US) Chimeric Antibody Sales Market Share (2011-2016)

Table Wako Pure Chemical Industries Ltd. (Japan) Basic Information List

Table Wako Pure Chemical Industries Ltd. (Japan) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Wako Pure Chemical Industries Ltd. (Japan) Chimeric Antibody Sales Market Share (2011-2016)

Table Waters Corp. (US) Basic Information List

Table Waters Corp. (US) Chimeric Antibody Sales, Revenue, Price and Gross Margin (2011-2016)

Table Waters Corp. (US) Chimeric Antibody Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Chimeric Antibody

Figure Manufacturing Process Analysis of Chimeric Antibody

Figure Chimeric Antibody Industrial Chain Analysis

Table Raw Materials Sources of Chimeric Antibody Major Manufacturers in 2015

Table Major Buyers of Chimeric Antibody

Table Distributors/Traders List

Figure USA Chimeric Antibody Production and Growth Rate Forecast (2016-2021)

Figure USA Chimeric Antibody Revenue and Growth Rate Forecast (2016-2021)

Table USA Chimeric Antibody Production Forecast by Type (2016-2021)

Table USA Chimeric Antibody Consumption Forecast by Application (2016-2021)